Related Experiment Video
Updated: Jun 5, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Timing Matters: Optimizing Oncology Involvement in Pediatric Neuro-Oncology Pathways in Saudi Arabia
Ali H Algiraigri1,2, Mohammed Basamh3, Ghadeer Alobaid4
1Department of Hematology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
Pediatric neuro-oncology care coordination is inconsistent, with oncologists often involved late. Standardizing practices and early consultations can improve outcomes for children with central nervous system tumors.
Area of Science:
- Pediatric Oncology
- Neurosurgery
- Healthcare Coordination
Background:
- Effective care coordination between pediatric neurosurgery and oncology is vital for optimal outcomes in pediatric central nervous system (CNS) tumors.
- Current practices often delay oncological involvement until after surgery, leading to treatment delays and redundant procedures.
Purpose of the Study:
- To investigate current care coordination practices and identify barriers in pediatric neuro-oncology.
- To explore opportunities for optimizing care pathways for pediatric CNS tumors.
Main Methods:
- A cross-sectional survey was distributed to neurosurgeons and pediatric oncologists in Saudi Arabia.
- The survey assessed the timing of oncological input, neuroimaging, cerebrospinal fluid (CSF) cytology collection, and views on care coordination.
Main Results:
- Only 29% of participants reported presurgical oncology involvement; 58% involved oncologists post-pathology.
- Significant variability existed in neuroimaging protocols, with delayed spinal MRI common.
- Lack of multidisciplinary tumor boards and perceived lack of necessity for early oncology input were key barriers.
Conclusions:
- Pediatric neuro-oncology coordination practices exhibit considerable heterogeneity.
- Implementing early oncology consultations, standardized imaging, and integrated care discussions can address critical care delivery gaps.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Cancer Survival Analysis
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
